Maze Therapeutics Inc

MAZENASDAQ · USD
22.52USD0.00 (-3.93%)
139

Maze Therapeutics Inc (MAZE) Option Chain

As of September 18, 2026, Maze Therapeutics Inc is trading at $22.52, a -3.93% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 69.6%. IV Rank is 8%.

Read more

Tracking the MAZE option chain helps you see every strike and expiry on Maze Therapeutics Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Maze Therapeutics Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of MAZE options activity at a glance. Use our scanner to monitor the MAZE option chain in real time and filter for the MAZE options trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For MAZE stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the MAZE option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where MAZE stock options are being actively traded and where they are not.

Maze Therapeutics, Inc., a clinical stage biopharmaceutical company, develops small molecule precision medicines for the treatment of renal, cardiovascular, related metabolic diseases, and obesity in the United States. Its lead programs includes MZE829, an oral small molecule inhibitor of apolipoprotein L1, which is in phase II clinical trial for the treatment of patients with APOL1 kidney disease; and MZE782, an oral small molecule inhibitor of the solute transporter SLC6A19, which is in phase I clinical trial for the treatment of chronic kidney disease. Maze Therapeutics, Inc. was formerly known as Modulus Therapeutics, Inc.

and changed its name to Maze Therapeutics, Inc. in September 2018. The company was incorporated in 2017 and is based in South San Francisco, California.

Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Maze Therapeutics Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen MAZE options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of MAZE stock options — let the full option chain come to you, pre-filtered and ready to trade.

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV percentile43.25% Neutral
  • Market cap (M$)1,251
  • 52 weeks high-58.02%
  • 52 weeks low2.32%
  • Analyst recommendationStrong Buy
    1.00
  • Target price$62.55
    177.75% above the current stock price
  • Dividend
  • Payout ratio
  • Earnings date2026-11-05
  • P/E
  • Future P/E
  • EPS (ttm)-2.53
  • EPS growth next 5 years-5.40%

As of September 18, 2026

2026-10-16
5 strikes
Default
CALLsPUTs
Prob. OTM %Open InterestVolumeExtrinsic ValueIntrinsic ValueBidAskStrikeMoneyness %BidAskIntrinsic ValueExtrinsic ValueVolumeOpen InterestProb. OTM %
10.59000.485.023.507.5017.50-22.295.000.005.000089.41
29.27000.932.521.405.5020.00-11.191.700.001.700070.73
52.98204.880.024.9022.50-0.094.900.004.900047.02
73.55204.900.004.9025.00+11.011.004.902.480.470126.45
94.4150001.900.001.9030.00+33.215.509.507.480.020205.59

As of September 18, 2026

Scan the full option chain in one place

Browse the full MAZE option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.

Start your 14-day free trial